Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Int J Cancer
    December 2025
  1. DE SALINS V, Martinez-Tapia C, Gay P, Morel A, et al
    The Fibrosis-4 score is associated with overall mortality and severe haematological toxicity in older patients with cancer: Analysis of two prospective cohort studies.
    Int J Cancer. 2025;157:2506-2520.
    >> Share

  2. LUO S, Qiao S, Liu L, Jia Y, et al
    Comprehensive molecular characterization of Rho GTPases and their regulators across human cancers.
    Int J Cancer. 2025;157:2309-2324.
    >> Share

    November 2025
  3. SHEN QM, Li ZY, Wang J, Zou YX, et al
    Prediagnostic plasma metabolite concentrations and liver cancer risk: A nested case-control study with long follow-up in the Shanghai Women's Health Study.
    Int J Cancer. 2025;157:1805-1817.
    >> Share

  4. SHEN Q, Shi S, Wang H, Zhang S, et al
    Serum 25-hydroxyvitamin D, vitamin D-related variants, and risk of chronic liver disease.
    Int J Cancer. 2025;157:1781-1794.
    >> Share

    October 2025
  5. ZHENG Y, Han J, Qu Y, Wang J, et al
    Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian population.
    Int J Cancer. 2025 Oct 23. doi: 10.1002/ijc.70204.
    >> Share

  6. YANG Z, Wang L, Kang F
    Immunogenic cell death: A promising mechanism involving different therapeutic strategies for liver cancer.
    Int J Cancer. 2025;157:1267-1276.
    >> Share

    September 2025
  7. HAN Y, Shaw VR, Byun J, Thrift AP, et al
    Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits.
    Int J Cancer. 2025 Sep 27. doi: 10.1002/ijc.70136.
    >> Share

  8. VAN DER GEEST LG, van der Mark M, Verheij J, Farina Sarasqueta A, et al
    Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry.
    Int J Cancer. 2025 Sep 12. doi: 10.1002/ijc.70145.
    >> Share

    August 2025
  9. GUERRERO JJG, Encarnacion PC, Del Rosario MAS, Ora MAS, et al
    Genetic variants underlying precancerous conditions of hepatocellular carcinoma.
    Int J Cancer. 2025 Aug 20. doi: 10.1002/ijc.70092.
    >> Share

  10. ZHAO L, Cheng J, Zheng Y, Wu J, et al
    Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma.
    Int J Cancer. 2025 Aug 16. doi: 10.1002/ijc.70091.
    >> Share

  11. LI H, Feng Y, Wang Z, Li X, et al
    Advances in the management of ovarian cancer liver metastasis.
    Int J Cancer. 2025 Aug 16. doi: 10.1002/ijc.70065.
    >> Share

    July 2025
  12. HUANG F, Jiang H, Shen M, Zhang C, et al
    Plasma metabolomic profiling for hepatocellular carcinoma diagnosis and microvascular invasion prediction.
    Int J Cancer. 2025 Jul 22. doi: 10.1002/ijc.70055.
    >> Share

  13. AIELLO C, Felli E, Musarra T, Nevi L, et al
    Rewriting the MASLD-associated hepatocellular carcinoma script: Targeting epigenetics and metabolism.
    Int J Cancer. 2025 Jul 22. doi: 10.1002/ijc.70047.
    >> Share

  14. PHAM YT, Wang R, Behari J, Chen GC, et al
    Plant-based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort study.
    Int J Cancer. 2025 Jul 19. doi: 10.1002/ijc.70057.
    >> Share

  15. YU C, Lin F, Tian C, Guo H, et al
    Baseline vitamin D status, genetic susceptibility, and the risk of incident hepatocellular carcinoma.
    Int J Cancer. 2025 Jul 3. doi: 10.1002/ijc.70003.
    >> Share

    June 2025
  16. PASSEN CV, Krug J, Weiss L, Abdou MM, et al
    Integrin beta6 expression in colorectal cancer cells promotes liver metastasis through enhanced adhesion to endothelial fibronectin.
    Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35504.
    >> Share

    May 2025
  17. PATEL DP, Loffredo CA, Pupacdi B, Rabibhadana S, et al
    Associations of chronic liver disease and liver cancer with glyphosate and its metabolites in Thailand.
    Int J Cancer. 2025;156:1885-1897.
    >> Share

    March 2025
  18. AGLAGO EK, Ramos I, Keski-Rahkonen P, Chatziioannou C, et al
    Alcohol and smoking habits in association with hepatocellular carcinoma risk.
    Int J Cancer. 2025 Mar 18. doi: 10.1002/ijc.35401.
    >> Share

  19. GAO Y, Cheng AL, Li LX, Parent N, et al
    Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial.
    Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35407.
    >> Share

  20. JIANG X, Zhang Q, Zheng Z, Shen Z, et al
    Latent class analysis-derived classification for cancer-specific death stratification of hepatocellular carcinoma.
    Int J Cancer. 2025 Mar 12. doi: 10.1002/ijc.35399.
    >> Share

  21. CHIVITE-LACABA M, Justo I, Utrero-Rico A, Caso O, et al
    Delineation of monocytic and early-stage myeloid-derived suppressor cells in the peripheral blood of patients with hepatocarcinoma.
    Int J Cancer. 2025 Mar 7. doi: 10.1002/ijc.35390.
    >> Share

    January 2025
  22. HE M, Xie W, Yuan Z, Chen J, et al
    Comparing PD-L1 and PD-1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single-center, real-world study.
    Int J Cancer. 2025 Jan 20. doi: 10.1002/ijc.35341.
    >> Share

    December 2024
  23. HUANG M, Song C, Zhou X, Wang H, et al
    Tissue-matched analysis of MRI evaluating the tumor infiltrating lymphocytes in hepatocellular carcinoma.
    Int J Cancer. 2024 Dec 5. doi: 10.1002/ijc.35281.
    >> Share

  24. REMOND M, Smolenschi C, Tarabay A, Gelli M, et al
    Clinical and molecular features of early onset pancreatic adenocarcinoma.
    Int J Cancer. 2024;155:1969-1981.
    >> Share

    November 2024
  25. TRAILIN A, Ali E, Ye W, Pavlov S, et al
    Prognostic assessment of T-cells in primary colorectal cancer and paired synchronous or metachronous liver metastasis.
    Int J Cancer. 2024 Nov 7. doi: 10.1002/ijc.35252.
    >> Share

  26. WATLING CZ, Kelly RK, Watts EL, Graubard BI, et al
    Total testosterone, sex hormone-binding globulin, and free testosterone concentrations and risk of primary liver cancer: A prospective analysis of 200,000 men and 180,000 postmenopausal women.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35244.
    >> Share

    October 2024
  27. LIU J, Zhang X, Lin J, Dai C, et al
    HBcrAg is associated with prognosis of hepatitis B virus-related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy.
    Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35224.
    >> Share

    September 2024
  28. HO NT, Abe SK, Rahman MS, Islam R, et al
    Diabetes is associated with increased liver cancer incidence and mortality in adults: A report from Asia Cohort Consortium.
    Int J Cancer. 2024;155:854-870.
    >> Share

    August 2024
  29. HUANG H, Zhao Y, Deng Y, Zhan Z, et al
    Optimal therapeutic strategies for hepatic metachronous oligometastatic nasopharyngeal carcinoma: Insights from a retrospective study.
    Int J Cancer. 2024 Aug 26. doi: 10.1002/ijc.35139.
    >> Share

  30. BUI TT, Park E, Kang HY, Oh JK, et al
    Combined effects of smoking and alcohol consumption on the risk of liver cancer according to metabolic syndrome: A nested case-control study in South Korea.
    Int J Cancer. 2024;155:654-665.
    >> Share

    July 2024
  31. VAZ J, Jepsen P, Stromberg U, Midlov P, et al
    Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study.
    Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35097.
    >> Share

    June 2024
  32. ZHAO L, Zhang X, Birmann BM, Danford CJ, et al
    Pre-diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population-based cohort studies from the United States and the United Kingdom.
    Int J Cancer. 2024 Jun 11. doi: 10.1002/ijc.35054.
    >> Share

  33. KARA-ALI GH, Cano L, Dion S, Imerzoukene G, et al
    Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation.
    Int J Cancer. 2024;154:1999-2013.
    >> Share

    May 2024
  34. PUPACDI B, Loffredo CA, Budhu A, Rabibhadana S, et al
    The landscape of etiological patterns of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in Thailand.
    Int J Cancer. 2024 May 18. doi: 10.1002/ijc.35034.
    >> Share

  35. GERBER TS, Ridder DA, Goeppert B, Brobeil A, et al
    N-cadherin: A diagnostic marker to help discriminate primary liver carcinomas from extrahepatic carcinomas.
    Int J Cancer. 2024;154:1857-1868.
    >> Share

    February 2024
  36. QIN XY, Shirakami Y, Honda M, Yeh SH, et al
    Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.
    Int J Cancer. 2024 Feb 21. doi: 10.1002/ijc.34893.
    >> Share

  37. YU Z, Bai X, Zhou R, Ruan G, et al
    Differences in the incidence and mortality of digestive cancer between Global Cancer Observatory 2020 and Global Burden of Disease 2019.
    Int J Cancer. 2024;154:615-625.
    >> Share

  38. XU FQ, Xu QY, Zhu ZJ, Jin L, et al
    Visceral and ectopic fat are more predictively associated with primary liver cancer than overall obesity from genetic sights: A Mendelian randomization study.
    Int J Cancer. 2024;154:530-537.
    >> Share

  39. JIANG L, Zhao N, Xu M, Pei J, et al
    Incidence trends of primary liver cancer in different geographical regions of China from 1978 to 2012 and projections to 2032: An age-period-cohort analysis.
    Int J Cancer. 2024;154:465-476.
    >> Share

  40. BARUPAL DK, Ramos ML, Florio AA, Wheeler WA, et al
    Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case-control study within the ATBC cohort.
    Int J Cancer. 2024;154:454-464.
    >> Share

    January 2024
  41. ZHAO G, Shi X, Zhang L, Liang H, et al
    Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
    Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34796.
    >> Share

  42. KIM MN, Zhang X, Ahn SH
    Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
    Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34797.
    >> Share

    November 2023
  43. ROSSARI F, Tada T, Suda G, Shimose S, et al
    alpha-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
    Int J Cancer. 2023 Nov 23. doi: 10.1002/ijc.34799.
    >> Share

    October 2023
  44. SOMMERHAUSER G, Karthaus M, Kurreck A, Ballhausen A, et al
    Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
    Int J Cancer. 2023 Oct 15. doi: 10.1002/ijc.34760.
    >> Share

  45. SIRIRUNGREUNG A, Lee PC, Hu YH, Liew Z, et al
    Maternal medically diagnosed infection and antibiotic prescription during pregnancy and risk of childhood cancer: A population-based cohort study in Taiwan, 2004 to 2015.
    Int J Cancer. 2023 Oct 4. doi: 10.1002/ijc.34744.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016